The natural history of dihydrolipoamide dehydrogenase deficiency in Israel
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12778 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Ben Pode-Shakked und 11 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Disease Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel. Hauptthemen laut MEDLINE: Dihydrolipoamide Dehydrogenase, Phenotype. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Dihydrolipoamide dehydrogenase (DLD) deficiency is an ultra‐rare autosomal‐recessive inborn error of metabolism, affecting no less than five mitochondrial multienzyme complexes. With approximately 30 patients reported to date, DLD deficiency was associated with three major clinical presentations: an early‐onset encephalopathic phenotype with metabolic acidosis, a predominantly hepatic presentation with liver failure, and a rare myopathic phenotype. To elucidate the demographic, phenotypic, and molecular characteristics of patients with DLD deficiency within the Israeli population, data were collected from metabolic disease specialists in four large tertiary medical centers in the center and south of Israel. Pediatric and adult patients with biallelic variants in DLD were included in the study. A total of 53 patients of 35 families were included in the cohort. Age at presentation ranged between birth and 10 years. Wide phenotypic variability was observed, from asymptomatic individuals in their sixth decade of life, to severe, neonatal‐onset disease with devastating neurological sequelae. Six DLD variants were noted, the most common of which was the c.685G>T (p.G229C) variant in homozygous form (24/53 patients, 45.3%; 13/35 families), observed mostly among patients of Ashkenazi‐Jewish descent, followed by the homozygous c.1436A>T (p.D479V) variant, found in 20 patients of Bedouin descent (37.7%; 16/35 families). Overall, patients did not necessarily present as one of the previously described distinct clinical phenotypes. DLD deficiency is a panethnic disorder, with significant phenotypic variability, and comprises a continuum, rather than three distinct clinical presentations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Disease Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
- School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
- Metabolic Disease Unit, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel.
- Department of Genetics, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- Pediatrics Department, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
- Pediatric Ambulatory Day Unit, Soroka Medical Center, Beer Sheva, Israel.
ORCID-Profile: Orna Staretz-Chacham
Zitieren
APA
Pode-Shakked, B., Landau, Y. E., Shaul Lotan, N., Manor, J., Haham, N., Kristal, E., Hershkovitz, E., Hazan, G., Haham, Y., Almashanu, S., Anikster, Y., & Staretz-Chacham, O. (2024). The natural history of dihydrolipoamide dehydrogenase deficiency in Israel. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12778
Vancouver
Pode-Shakked B, Landau YE, Shaul Lotan N, Manor J, Haham N, Kristal E, et al. The natural history of dihydrolipoamide dehydrogenase deficiency in Israel. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12778
BibTeX
@article{PodeShakked2024,
author = {Pode-Shakked, Ben and Landau, Yuval E and Shaul Lotan, Nava and Manor, Joshua and Haham, Nitsan and Kristal, Eyal and Hershkovitz, Eli and Hazan, Guy and Haham, Yarden and Almashanu, Shlomo and Anikster, Yair and Staretz-Chacham, Orna},
title = {The natural history of dihydrolipoamide dehydrogenase deficiency in Israel},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12778}
}
EUVIMED